Trends Rising Demand for Weight Management Solutions Advancements in Drug Formulations Integration of Digital Health Technologies Opportunities Innovations in Drug Delivery Systems Increasing Prevalence of Obesity and Diabetes Rising Investment in Diabetes and Obesity Research GLP-1 Drug Market Summary The Global GLP-1 Drug Market size was valued at USD 10.77 Billion in 2024, and the market is projected to grow from USD 12.19 Billion in 2025 to USD 42.0 Billion by 2035, registering a CAGR of 13.17% during the forecast period 20252035
Pharma Roundup: Mounjaro Shows Advantages in Type 2 Diabetes, Immune System Linked to Long Covid Symptoms Nicholas Jacobus Key Takeaways Surpass-Early randomized ~800 adults with 4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators
It is not a medicinal product, is not an approved medicine (CagriSema remains in development), is not intended for use in humans or animals, and does not replace medical advice
Before starting a GLP-1, discuss kidney health with your provider if you have kidney disease, diabetes, high blood pressure, recent dehydration, or take medications that affect the kidneys
Daily life can expose the body to oxidative stress from factors such as environmental exposure, exercise, and general lifestyle habits